Inflammatory cytokines in small intestinal mucosa of patients with potential coeliac disease

Clinical and Experimental Immunology

Volumn 128, Issue 1, 2002, Pages 94-101

  Westerholm Ormio, M ^a   Garioch, J ^b   Ketola, I ^a   Savilahti, E ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b WEST NORWICH HOSPITAL   (United Kingdom)

Author keywords

Cytokines; Immunohistochemistry; MRNA in situ hybridization; Potential coeliac disease; T cell subsets

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; GLUTEN; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CELIAC DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATITIS HERPETIFORMIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; INTESTINE MUCOSA; JEJUNUM BIOPSY; LAMINA PROPRIA; LYMPHOCYTE; MACROPHAGE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SMALL INTESTINE; TH1 CELL;

ADOLESCENT; ADULT; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HLA-D ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-4; INTESTINAL MUCOSA; INTESTINE, SMALL; KI-67 ANTIGEN; LYMPHOCYTES; MALE; RECEPTORS, ANTIGEN, T-CELL; RNA, MESSENGER;

EID: 0036248067     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01798.x     Document Type: Article

References (44)

1. Celiac sprue
2. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue')
3. Coeliac disease
4. Current concepts of celiac disease pathogenesis
5. The role of activated T cells in transformed intestinal mucosa
6. Gluten-sensitive enteropathy and other immunologically mediated enteropaties
7. Identification of tissue transglutaminase as the autoantigen of celiac disease
8. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease
9. Follow-up of patients positive in reticulin and gliadin antibody tests with normal small-bowel biopsyfindings
10. Latent coeliac disease in Italy
11. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal
12. Dermatitis herpetiformis. Jejunal findings and skin response to gluten free diet
13. Dermatitis herpetiformis. Coeliac disease of the skin
14. Clinical and pathological spectrum of coeliac disease- active, silent, latent, potential
15. Latent celiac sprue
16. Normal small bowel biopsy followed by coeliac disease
17. Clinical, pathological, and antibody pattern of latent celiac disease: Report of three adult cases
18. Intestinal gamma/delta receptor-bearing T lymphocytes in celiac disease and inflammatory bowel diseases in children. Constant increase in celiac disease
19. Intraepithelial gamma delta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease
20. Increase in gamma/delta T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease
21. Immunohistochemical changes in the jejunum in first degree relatives of patients with coeliac disease and the coeliac disease marker DQ genes. HLA class II antigen expression, interleukin-2 receptor positive cells and dividing crypt cells
22. Small-bowel mucosal inflammation in reticulin or gliadin antibody-positive patients without villous atrophy
23. Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridisation
24. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge
25. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease
26. Analysis of interleukin-4 and interleukin-10 and their association with the lymphocytic infiltrate in the small intestine of patients with coeliac disease
27. Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor alpha in coeliac disease mucosa detected by immunohistochemistry
28. Expression of tumour necrosis factor-alpha, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease
29. + T cells in the jejunal epithelium of patients with coeliac disease and dermatitis herpetiformis is increased with age
30. Comparative evaluation of serologic tests for celiac disease: A European initiative toward standardization
31. IgA endomysium antibodies on human umbilical cord: An excellent diagnostic tool for celiac disease in childhood
32. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
33. Jejuna of patients with insulin-dependent diabetes mellitus (IDDM) show signs of immune activation
34. Immunohistochemical findings in jejunal specimens from patients with IgA deficiency
35. Whole mount in situ hybridization of vertebrate embryos
36. Expression and hormonal regulation of transcription factors GATA-4 and GATA-6 in the mouse ovary
37. Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-gamma
38. Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody
39. Majority of gliadin-specific T-cell clones from celiac small intestinal mucosa produce interferon-gamma and interleukin-4
40. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation
41. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma
42. Cytokine profile in coeliac disease
43. Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients
44. Spontaneous secretion of interferon gamma and interleukin 4 by human intraepithelial and lamina propria gut lymphocytes